Cargando…
Pimozide Inhibits the AcrAB-TolC Efflux Pump in Escherichia coli
Efflux pump inhibitors (EPIs) are attractive compounds to reverse multidrug-resistance in clinically relevant bacterial pathogens. In this study we tested the ability of the neuroleptic drug pimozide to inhibit the Escherichia coli AcrAB-TolC efflux pump, whose overproduction confers resistance to v...
Autores principales: | Bohnert, Jürgen A, Schuster, Sabine, Kern, Winfried V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613774/ https://www.ncbi.nlm.nih.gov/pubmed/23560030 http://dx.doi.org/10.2174/1874285801307010083 |
Ejemplares similares
-
Structure of the AcrAB-TolC multidrug efflux pump
por: Du, Dijun, et al.
Publicado: (2014) -
In situ structure and assembly of the multidrug efflux pump AcrAB-TolC
por: Shi, Xiaodong, et al.
Publicado: (2019) -
An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump
por: Wang, Zhao, et al.
Publicado: (2017) -
Mutations in the TolC Periplasmic Domain Affect Substrate Specificity of the AcrAB-TolC Pump
por: Marshall, Robert L., et al.
Publicado: (2020) -
Expression of the AcrAB Components of the AcrAB-TolC Multidrug Efflux Pump of Yersinia enterocolitica Is Subject to Dual Regulation by OmpR
por: Raczkowska, Adrianna, et al.
Publicado: (2015)